SMTL ID : 5fbn.2 (1 other biounit)

BTK kinase domain with inhibitor 1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 3 residues within 4Å: Chain A: R.230 Ligands: 5WE.4, 5WE.5 Ligand excluded by PLIP

1 x 5WF: 4-[8-azanyl-3-[(3~{R})-1-(3-methyloxetan-3-yl)carbonylpiperidin-3-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-[4-(trifluoromethyl)pyridin-2-yl]benzamide(Non-covalent)

5WF.2: 24 residues within 4Å: Chain A: L.20, G.21, T.22, G.23, V.28, A.40, K.42, F.54, A.58, M.61, L.72, I.84, T.86, E.87, Y.88, M.89, G.92, C.93, N.96, L.140, S.150, D.151, F.152, L.154 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:V.28, A:K.42, A:L.72, A:L.72, A:T.86, A:L.140, A:L.154 Hydrogen bonds: A:T.86, A:E.87, A:M.89, A:C.93, A:S.150, A:D.151, A:D.151, A:F.152

3 x 5WE: 4-[8-azanyl-3-[(2~{S})-1-[4-(dimethylamino)butanoyl]pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-(1,3-thiazol-2-yl)benzamide(Non-covalent)

5WE.3: 7 residues within 4Å: Chain A: S.6, W.33, Y.37, V.39, S.65, Q.71, Y.73 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.33, A:Y.37, A:V.39, A:Q.71, A:Y.73, A:Y.73, A:Y.73 Hydrogen bonds: A:S.65 Water bridges: A:S.65 5WE.4: 4 residues within 4Å: Chain A: E.236, Y.243 Ligands: CL.1, 5WE.5 2 PLIP interactions: 2 interactions with chain A Water bridges: A:R.230 Salt bridges: A:E.236 5WE.5: 7 residues within 4Å: Chain A: R.230, E.236, Y.239, T.240, Y.243 Ligands: CL.1, 5WE.4 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:E.236, A:T.240, A:Y.243 Water bridges: A:R.230, A:R.230, A:E.236, A:E.236, A:E.236, A:Y.239, A:Y.239 pi-Stacking: A:Y.239

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.6: 2 residues within 4Å: Chain A: T.15, F.16 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:F.16, A:F.16

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, J. et al., Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis. Acs Med.Chem.Lett. (2016)

Release Date

2016-02-03

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence